DK1209159T3 - Fremgangsmåde til fremstilling af vandfrie mirtazapinkrystaller - Google Patents
Fremgangsmåde til fremstilling af vandfrie mirtazapinkrystallerInfo
- Publication number
- DK1209159T3 DK1209159T3 DK01111102T DK01111102T DK1209159T3 DK 1209159 T3 DK1209159 T3 DK 1209159T3 DK 01111102 T DK01111102 T DK 01111102T DK 01111102 T DK01111102 T DK 01111102T DK 1209159 T3 DK1209159 T3 DK 1209159T3
- Authority
- DK
- Denmark
- Prior art keywords
- anhydrous mirtazapine
- mirtazapine crystals
- producing anhydrous
- substantially free
- crystals
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 3
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001785 mirtazapine Drugs 0.000 title abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000013557 residual solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000359891 | 2000-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1209159T3 true DK1209159T3 (da) | 2005-01-24 |
Family
ID=18831578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01111102T DK1209159T3 (da) | 2000-11-27 | 2001-05-08 | Fremgangsmåde til fremstilling af vandfrie mirtazapinkrystaller |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6660730B2 (de) |
| EP (1) | EP1209159B1 (de) |
| AT (1) | ATE282616T1 (de) |
| AU (1) | AU781974B2 (de) |
| CA (1) | CA2346195A1 (de) |
| DE (1) | DE60107189T2 (de) |
| DK (1) | DK1209159T3 (de) |
| ES (1) | ES2231340T3 (de) |
| IL (1) | IL146548A (de) |
| PT (1) | PT1209159E (de) |
| SI (1) | SI1209159T1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001038329A1 (en) * | 1999-11-24 | 2001-05-31 | Sumika Fine Chemicals Co., Ltd. | Anhydrous mirtazapine crystals and process for producing the same |
| US7838029B1 (en) | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
| US20070298107A1 (en) * | 2003-11-25 | 2007-12-27 | Aurobindo Pharma Ltd. | Pharmaceutical Compositions of Mirtazapine |
| JP5192707B2 (ja) | 2007-03-22 | 2013-05-08 | 住友化学株式会社 | ミルタザピンの製造方法 |
| PT3261645T (pt) | 2015-02-27 | 2021-06-17 | Dechra Ltd | Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| CZ20013658A3 (cs) * | 1999-04-19 | 2002-08-14 | Teva Pharmaceutical Industries Ltd. | Syntéza a krystalizace sloučenin obsahujících piperazinový kruh |
-
2001
- 2001-04-27 US US09/842,871 patent/US6660730B2/en not_active Expired - Fee Related
- 2001-04-30 AU AU40301/01A patent/AU781974B2/en not_active Ceased
- 2001-05-02 CA CA002346195A patent/CA2346195A1/en not_active Abandoned
- 2001-05-08 SI SI200130260T patent/SI1209159T1/xx unknown
- 2001-05-08 ES ES01111102T patent/ES2231340T3/es not_active Expired - Lifetime
- 2001-05-08 EP EP01111102A patent/EP1209159B1/de not_active Expired - Lifetime
- 2001-05-08 PT PT01111102T patent/PT1209159E/pt unknown
- 2001-05-08 DK DK01111102T patent/DK1209159T3/da active
- 2001-05-08 DE DE60107189T patent/DE60107189T2/de not_active Expired - Lifetime
- 2001-05-08 AT AT01111102T patent/ATE282616T1/de active
- 2001-11-19 IL IL146548A patent/IL146548A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60107189D1 (de) | 2004-12-23 |
| AU781974B2 (en) | 2005-06-23 |
| EP1209159A3 (de) | 2003-03-05 |
| ATE282616T1 (de) | 2004-12-15 |
| ES2231340T3 (es) | 2005-05-16 |
| AU4030101A (en) | 2002-06-06 |
| EP1209159B1 (de) | 2004-11-17 |
| DE60107189T2 (de) | 2005-06-30 |
| US6660730B2 (en) | 2003-12-09 |
| CA2346195A1 (en) | 2002-05-27 |
| PT1209159E (pt) | 2005-01-31 |
| IL146548A0 (en) | 2002-07-25 |
| SI1209159T1 (en) | 2005-04-30 |
| IL146548A (en) | 2007-08-19 |
| EP1209159A2 (de) | 2002-05-29 |
| US20020065413A1 (en) | 2002-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002230842A1 (en) | Optical methods and systems for tissue analysis | |
| DE69915858D1 (de) | Mikrosphären aus polyvinylalkohol sowie verfahren zu deren herstellung | |
| ATE359286T1 (de) | Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotika | |
| EP1450847A4 (de) | Apo2-liganden/trail-formulierungen | |
| NO20033481D0 (no) | Integrerte reaktorer, samt fremgangsmåte for fremstilling og bruk av samme | |
| NO20033817D0 (no) | Fremgangsmåte for fraskillelse av hemicelluloser fra hemicelluloseholdig biomasse samt biomasse og hemicelluloser oppnådd ved fremgangsmåten | |
| TW200604579A (en) | Anisotropic optical devices and method for making same | |
| DE60228846D1 (de) | Neue mesogene, verfahren zu deren herstellung und verwendung | |
| TW200502029A (en) | Composition and process | |
| IL196900A0 (en) | Autologous t-cell vaccines compositions | |
| TW200610241A (en) | Semiconductor-laser component, optical device for a semiconductor-laser component and method for the production of an optical device | |
| ATE366710T1 (de) | Verfahren zur herstellung von molekularsieben | |
| ATE361334T1 (de) | Verfahren zur herstellung von hochreinem polycarbonat | |
| ATE282616T1 (de) | Verfahren zur herstellung von wasserfreien mirtazapin-kristallen. | |
| DK0763047T3 (da) | Ny fremgangsmåde til fremstilling af nucleosider | |
| FR2817974B1 (fr) | Micro-actionneur optique, composant optique utilisant le micro-actionneur, et procede de realisation d'un micro-actionneur optique | |
| WO2004090950A3 (de) | Räumlich hochauflelöstes erzeugen einer dauerhaften struktur | |
| ATE252589T1 (de) | Aluminosiloxanverbindungen und verfahren zu ihrer herstellung | |
| WO2000012480A3 (de) | Substituierte 3-aryl-pyrazole | |
| ATE246250T1 (de) | Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine | |
| PT793666E (pt) | Processo de sililacao | |
| EP0381130A3 (de) | Herstellung von alpha-ungesättigten Aminen | |
| ATE245431T1 (de) | Verfahren zur lösungsmittelextraktion von aktiven verbindungen aus zichorie | |
| ATE392413T1 (de) | Verfahren zur herstellung von beta-alaninamiden | |
| WO2002010160A3 (de) | Substituierte heterocyclylalkylamino-1,3,5-triazine |